Skip to content

Clinical trials

Phase 3 Macular Degeneration trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20081
20091
20132
20142
20153
20191
20203
20213
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer2
Ophthotech Corporation2
AbbVie1
Allergan1
Astellas Pharma Global Development, Inc.1
Bioeq GmbH1
Centre Hospitalier Intercommunal Creteil1
Centre de Recherche en Nutrition Humaine Rhone-Alpe1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration21
Choroidal Neovascularization7
Geographic Atrophy6
Wet Macular Degeneration6
Eye Diseases5
Retinal Diseases5
Vision Disorders5
Retinal Degeneration4
Blindness2
Diabetes Mellitus1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.